Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-04
2011-01-04
Loewe, Sun Jae Y. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S550000
Reexamination Certificate
active
07863317
ABSTRACT:
The present application describes modulators of MCP-1 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
REFERENCES:
patent: 6136834 (2000-10-01), Ohmoto et al.
patent: 6262080 (2001-07-01), Warshawsky et al.
patent: 6706712 (2004-03-01), Cherney
patent: 2003/0060459 (2003-03-01), Carter et al.
patent: 2003/0216434 (2003-11-01), Cherney
patent: 2004/0186143 (2004-09-01), Carter et al.
patent: 2004/0235835 (2004-11-01), Carter
patent: 2004/0235836 (2004-11-01), Cherney
patent: WO 2005/021499 (2005-03-01), None
U.S. Appl. No. 10/922,406, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,619, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,538, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/776,828, filed Feb. 11, 2004, Cherney et al.
Bristol--Myers Squibb Company
Duncan Laurelee L.
Loewe Sun Jae Y.
LandOfFree
Lactams of alkylated acyclic diamine derivatives as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lactams of alkylated acyclic diamine derivatives as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactams of alkylated acyclic diamine derivatives as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2714821